Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2018

May 12, 2018

30786_dirs_2018-05-11_8e51a644-c0b9-47ed-bd77-56c17f898def.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-05-11

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-05-11 Bio-Rad B Common Stock M 37500 $88.48 Acquired 280418 Direct
2018-05-11 Bio-Rad B Common Stock F 24273 $284.98 Disposed 256145 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-05-11 Non-Qualified Stock Option (right to buy) $88.48 M 37500 Disposed 2018-06-11 Bio-Rad B Common Stock (37500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 12717 Indirect
Bio-Rad B Common Stock 4060054 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The option vested in five equal annual installments beginning on June 11, 2009.